Ramiro Sanchez's most recent trade in Alto Neuroscience Inc. was a trade of 3,806 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alto Neuroscience Inc | Ramiro Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,806 | 3,806 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Ramiro Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Ramiro Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 3,928 | 3,928 | - | - | Stock Option (right to buy) | |
| Rapport Therapeutics Inc | Ramiro Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) |